SLC2A2 and diabetic kidney disease: Renal proximal tubule cell–specific ablation of Glut2 has been demonstrated to ameliorate the progress of DKD in mice because of suppression of cannabinoid-1 receptor stimulation and mTOR complex 1 (mTORC1) activity (21, 22).